NEW YORK (360Dx) – Scientists from the Boston University School of Medicine have developed a test that could help identify patients with transthyretin amyloid cardiomyopathy (ATTR), a significant, but difficult to diagnose, cause of heart failure.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.